2 recruiting, 1 active not recruiting, 1 completed, 1 not yet recruiting. 5 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 5 | Recruiting 2, Active not recruiting 1, Completed 1, Not yet recruiting 1 |
| Phase 2 | 1 | Not yet recruiting 1 |
Follow Elderly Patients: new trials by email Literature Review of Elderly Patients trials Research Report on Elderly Patients
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Venetoclax-Azacitidine in Combination With Chidamide and CAG in Fit Older Patients With Acute Myeloid Leukaemia the standard "3+7" regimen, Azacytidine; Cytarabine; Aclacinomycin; Chidamide; Venetoclax; Granulocyte - Newly Diagnosed Acute Myeloid Leukemia (AML), Elderly Patients | Phase 3 | Recruiting | Chinese PLA General Hospital | 120 | 2024-11-18 | 2026-08-20 |
| Prephase Treatment With Prednisone +/- Vitamin D Supplementation Followed by Immunochemotherapy Vitamin D3 (Cholecalciferol), RCHOP o R-miniCHOP at standard doses - Diffuse Large B-Cell Lymphoma, Elderly Patients | Phase 3 | Recruiting | Fondazione Italiana Linfomi - ETS | 430 | 2021-03-23 | 2022-08-26 |
| Neoadjuvant Chemotherapy Plus Surgery Versus Surgery First For Elderly Gastric Cancer Patients Chemotherapy, Curative gastrectomy - Gastric Cancer, Chemotherapy Effect | Phase 2 / Phase 3 | Not yet recruiting | BIRENDRA KUMAR SAH | 232 | 2021-01-01 | 2020-12-21 |
| QoL in mCRC Elderly Patients Receiving First-line Therapy Based on Simplified Geriatric Parameters. OPTIMOX-bevacizumab, Capecitabine plus bevacizumab - Elderly Patients, Metastatic Colorectal Cancer | Phase 3 | Active not recruiting | GERCOR - Multidisciplinary Oncology Cooperative Group | 49 | 2019-06-14 | 2025-07-18 |
| Treatment Outcome in Elderly Patients chemotherapy treatment (see arm) + norethandrolone, chemotherapy treatment (see arms) - AML, Elderly Patients | Phase 3 | Completed | University Hospital, Grenoble | 330 | 2002-06-01 | 2008-06-18 |
Colorectal Neoplasms (1) · Leukemia, Myeloid, Acute (1) · Lymphoma, Large B-Cell, Diffuse (1) · Stomach Neoplasms (1)
Neoplasms (4) · Digestive System Diseases (2) · Digestive System Neoplasms (2) · Gastrointestinal Diseases (2) · Gastrointestinal Neoplasms (2) · Hemic and Lymphatic Diseases (2) · Neoplasms by Histologic Type (2) · Neoplasms by Site (2) · Colonic Diseases (1) · Hematologic Diseases (1) · Immune System Diseases (1) · Immunoproliferative Disorders (1) · Intestinal Diseases (1) · Intestinal Neoplasms (1) · Leukemia (1)
Azacitidine (1) · Bevacizumab (1) · Capecitabine (1) · Cholecalciferol (1) · Cytarabine (1) · Drug Therapy (1) · Induction Chemotherapy (1) · Leucovorin (1) · Maintenance Chemotherapy (1) · N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide (1) · Norethandrolone (1) · aclacinomycins (1) · venetoclax (1)
BIRENDRA KUMAR SAH (1) · Chinese PLA General Hospital (1) · Fondazione Italiana Linfomi - ETS (1) · GERCOR - Multidisciplinary Oncology Cooperative Group (1) · University Hospital, Grenoble (1)
France (2) · China (1) · Italy (1)
Dahong Liu, Doctor (1) · Francesco Merli, Dott. (1) · Zhenggang Zhu (1)